- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01583998
Electronic-Measurement Based Care for Major Depressive Disorder (e-MBC)
Electronic-Measurement Based Care (e-MBC) for Major Depressive Disorder (MDD)
Study Overview
Detailed Description
Major Depressive Disorder (MDD) is a serious, debilitating illness that affects persons of all ages, races, and socioeconomic backgrounds. Despite the availability of new and effective treatments over the last 20 years, recent evidence continues to demonstrate high rates of inadequate antidepressant medication treatment in practice settings. Practitioners vary widely in how they assess treatment outcomes, including symptoms, function, side-effect frequency and burden. In contrast to other chronic medical conditions such as diabetes mellitus, back/neck problems, or hypertension, clinicians treating patients with depression do not routinely evaluate measurement-based care (MBC) treatment parameters. MBC provides an essential framework for physicians to approach depression treatment consistent with their approach for other common disorders. MBC is an effective means to provide patient-centered care for MDD, personalizing treatment decisions based on patient progress and their ability to tolerate the medication.
A key barrier to patient adherence with MBC treatment is that the approach requires patients to return to the clinic for several follow-up visits. The necessity of treatment visits varies widely among patients. Thus far, physicians using MBC for the treatment of MDD do not have a complete set of tools that are practical to use and allow treatment to be truly personalized patient-centered care.
One solution to this problem is to use an enhanced electronic personal health record, such as the MyChart system. This system could be easily modified to include the central elements of MBC for depression to allow for the systematic assessment of a patient's depressive symptom severity, antidepressant tolerability, and adherence to treatment in a timely fashion. This information would be available to allow the physician to provide patient-centered care by utilizing standardized assessment to personalize treatment for depression. The proposed electronic-MBC (e-MBC) addresses a critical gap in depression treatment by providing regularly-scheduled drug monitoring and continuity of care, in the face of limited patient and clinic resources.
Information technology (IT) systems have been effectively integrated into the medical treatment of patients but have yet to have substantial impact at the point-of-care. Applying e-MBC methods allows physicians to utilize existing information technology systems to improve depression treatment at the point-of-care. The key features of the proposed e-MBC approach are that it can be seamlessly integrated into standard clinical practice, and requires no additional IT knowledge or training to be effectively utilized by physicians and clinical staff.
In this pilot study the investigators will compare standard treatment (office based antidepressant management) to a group receiving scheduled electronic MBC assessments via an enhanced personal health record system (e-MBC). To date, no one has published feasibility studies evaluating the use of personal health records for measurement-based care of depression patients.
Study Type
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Texas
-
Dallas, Texas, United States, 75390
- The University of Texas Southwestern Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients must plan to continue living in the clinic area throughout the study
- Patients must be 18 to 65 years of age
- Patients must give written informed consent
- Patient must have clinically significant depression and/or starting an antidepressant treatment and/or experiencing a antidepressant treatment change
- Patients must be willing and able to use MyChart to communicate with their physician
Exclusion Criteria:
- Patients with a current Axis I diagnosis of Bipolar disorder or Schizophrenia
- Patients who cannot read and understand English since all research instruments are not yet translated and validated in Spanish or other languages
- Patients whose clinical status requires inpatient treatment at the time of baseline interview.
- Current substance abuse or dependence
- Patients with current suicidal ideation
- Patients with general medical conditions that contraindicate antidepressant medications
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: e-MBC
Patients will receive e-MBC
|
antidepressant treatment
Other Names:
|
|
NO_INTERVENTION: Treatment as Usual Control
Patients receive standard treatment
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient Health Questionnaire (PHQ-9)
Time Frame: Every 30 days for 6 months
|
Depression severity assessment
|
Every 30 days for 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Frequency, Intensity, and Burden of Side Effect Rating (FIBSER)
Time Frame: Every 30 days for 6 months
|
Antidepressant side effects
|
Every 30 days for 6 months
|
|
Patient Satisfaction Questionnaire (PSQ)
Time Frame: At the end of study treament (6 months from the first assessment)
|
Assesses satisfaction with care
|
At the end of study treament (6 months from the first assessment)
|
|
Physician Evaluation of Ease of Use Survey (EEUS)
Time Frame: At the end of study treament (6 months from the first assessment)
|
Physicians' perception of the ease of use of the e-MBC system
|
At the end of study treament (6 months from the first assessment)
|
|
Physician Evaluation of Usefulness Survey (EUS)
Time Frame: At the end of study treament (6 months from the first assessment)
|
Physicians' perception of the usefulness of the e-MBC system
|
At the end of study treament (6 months from the first assessment)
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1R03MH092509-01 (NIH)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.